Classification of lipid disorders in chronic hemodialyzed patients.
The aim of our study was to introduce the classification given by the European Atherosclerosis Society (A B C D E groups) for monitoring lipid disorders in chronic renal failure patients during the first year of dialysis therapy (DT). Studies were carried out in 41 chronically uremic patients (19 F, 22 M). Before the start of DT, and then every 2 months, following parameters were determined in the serum: total cholesterol, HDL-cholesterol and triglycerides. Moreover, electrophoresis of serum lipoproteins were also performed. At the start of the DT 63% of chronically uremic patients had normal values of basic lipid parameters, but this number decreased to only 29% after the first year of DT. We conclude that the modified A B C D E classification of lipid disorders in hemodialyzed patients is more convenient than the classic Fredrickson one used before.
Król
E
E
Department of Nephrology, Gdansk School of Medicine, Poland.
Rutkowski
B
B
Wróblewska
M
M
Badzio
T
T
D000293:Adolescent; D000328:Adult; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000145:classification / Q000150:complications* / Q000453:epidemiology; D006949:Hyperlipidemias / Q000145:classification* / Q000453:epidemiology; D015228:Hypertriglyceridemia / Q000145:classification / Q000150:complications* / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008074:Lipoproteins / Q000097:blood / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D006435:Renal Dialysis; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014511:Uremia / Q000150:complications / Q000628:therapy*
D008076:Cholesterol, HDL; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol